Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally. It offers chimeric antigen receptor T-cell therapy, dimeric antigen receptor T-cell therapy, and antibody-drug conjugates, as well as...
62 insider purchases on record · latest filing 2022-09-07.
Insiders have also filed 49 sale transactions at SRNE.